CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-17 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Sale | −19,000 | $37.30 | $709K | 2,115 |
| 2022-08-17 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option exercise | +45,000 | $2.71 | $122K | 47,115 |
| 2022-08-17 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option exercise · Incentive Stock Option | −19,000 | 48,400 | ||
| 2022-08-17 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option exercise · Incentive Stock Option | −45,000 | 15,000 | ||
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Option exercise | +75,000 | $2.78 | $209K | 102,692 |
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Option exercise | +45,000 | $9.02 | $406K | 147,692 |
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Sale | −120,000 | $37.66 | $4.5M | 27,692 |
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Option exercise · Incentive Stock Option | −75,000 | 25,000 | ||
| 2022-08-15 | Marucci Anthony S PRESIDENT & CEO | Option exercise · Incentive Stock Option | −45,000 | 26,665 | ||
| 2022-08-15 | Wright Richard M. SR. VP & CCO | Option exercise | +15,328 | $10.38 | $159K | 15,536 |
| 2022-08-15 | Wright Richard M. SR. VP & CCO | Sale | −15,328 | $37.71 | $578K | 208 |
| 2022-08-15 | Wright Richard M. SR. VP & CCO | Option exercise · Incentive Stock Option | −15,328 | 26,672 | ||
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Option exercise | +3,876 | $9.02 | $35K | 28,254 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Option exercise | +13,671 | $2.78 | $38K | 41,925 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −14,261 | $36.76 | $524K | 27,664 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −2,065 | $35.38 | $73K | 25,599 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Sale | −1,221 | $34.62 | $42K | 24,378 |
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Option exercise · Incentive Stock Option (Right to Buy) | −3,876 | 3,201 | ||
| 2022-08-12 | Martin Samuel Bates SVP AND CFO | Option exercise · Incentive Stock Option (Right to Buy) | −13,671 | 10,750 | ||
| 2022-08-11 | Martin Samuel Bates SVP AND CFO | Option exercise | +2,453 | $9.02 | $22K | 26,831 |
Page 9 of 10 · 182 trades